company background image
1696

Sisram Medical SEHK:1696 Stock Report

Last Price

HK$11.62

Market Cap

HK$5.4b

7D

-4.0%

1Y

-20.2%

Updated

16 Aug, 2022

Data

Company Financials +
1696 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth4/6
Past Performance5/6
Financial Health6/6
Dividends0/6

1696 Stock Overview

Sisram Medical Ltd, an investment holding company, designs, develops, manufactures, and sells energy-based aesthetic medical, minimally invasive treatment systems, and non-energy based devices and cosmeceuticals in the Asia Pacific, Europe, North America, Latin America, the Middle East, and Africa.

Sisram Medical Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Sisram Medical
Historical stock prices
Current Share PriceHK$11.62
52 Week HighHK$16.48
52 Week LowHK$4.80
Beta1.09
1 Month Change-3.01%
3 Month Change48.21%
1 Year Change-20.19%
3 Year Change233.91%
5 Year Changen/a
Change since IPO43.10%

Recent News & Updates

Aug 01
Should You Think About Buying Sisram Medical Ltd (HKG:1696) Now?

Should You Think About Buying Sisram Medical Ltd (HKG:1696) Now?

Sisram Medical Ltd ( HKG:1696 ), might not be a large cap stock, but it received a lot of attention from a substantial...

Shareholder Returns

1696HK Medical EquipmentHK Market
7D-4.0%0.5%-0.2%
1Y-20.2%-52.8%-21.6%

Return vs Industry: 1696 exceeded the Hong Kong Medical Equipment industry which returned -52.8% over the past year.

Return vs Market: 1696 exceeded the Hong Kong Market which returned -21.6% over the past year.

Price Volatility

Is 1696's price volatile compared to industry and market?
1696 volatility
1696 Average Weekly Movement10.8%
Medical Equipment Industry Average Movement8.2%
Market Average Movement6.5%
10% most volatile stocks in HK Market12.6%
10% least volatile stocks in HK Market3.2%

Stable Share Price: 1696 is more volatile than 75% of Hong Kong stocks over the past 3 months, typically moving +/- 11% a week.

Volatility Over Time: 1696's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of Hong Kong stocks.

About the Company

FoundedEmployeesCEOWebsite
2013703Lior Dayanhttps://www.sisram-medical.com

Sisram Medical Ltd, an investment holding company, designs, develops, manufactures, and sells energy-based aesthetic medical, minimally invasive treatment systems, and non-energy based devices and cosmeceuticals in the Asia Pacific, Europe, North America, Latin America, the Middle East, and Africa. It offers products and treatments portfolio, including hair removal, skin rejuvenation, acne and acne scars, body and face contouring, pigmentation and skin resurfacing, fat grafting, dermal facial fillers, skin tissue remodelling injectables, personal care, aesthetic dentistry, trans epidermal delivery, cellulite treatment, stretch marks, vascular and pigmented lesions, hydradermabrasion, blepharoplasty-non surgical eyelid lift, liposuction, feminine health, and sexual rehabilitation. The company manufactures, distributes, and sells medical equipment.

Sisram Medical Fundamentals Summary

How do Sisram Medical's earnings and revenue compare to its market cap?
1696 fundamental statistics
Market CapHK$5.42b
Earnings (TTM)HK$244.90m
Revenue (TTM)HK$2.31b

22.1x

P/E Ratio

2.3x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
1696 income statement (TTM)
RevenueUS$294.29m
Cost of RevenueUS$127.43m
Gross ProfitUS$166.86m
Other ExpensesUS$135.62m
EarningsUS$31.25m

Last Reported Earnings

Dec 31, 2021

Next Earnings Date

Aug 19, 2022

Earnings per share (EPS)0.067
Gross Margin56.70%
Net Profit Margin10.62%
Debt/Equity Ratio1.8%

How did 1696 perform over the long term?

See historical performance and comparison

Dividends

1.3%

Current Dividend Yield

29%

Payout Ratio

Does 1696 pay a reliable dividends?

See 1696 dividend history and benchmarks
When do you need to buy 1696 by to receive an upcoming dividend?
Sisram Medical dividend dates
Ex Dividend DateAug 19 2022
Dividend Pay DateSep 02 2022
Days until Ex dividend2 days
Days until Dividend pay date16 days

Does 1696 pay a reliable dividends?

See 1696 dividend history and benchmarks
We’ve recently updated our valuation analysis.

Valuation

Is 1696 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Below Fair Value

  • Significantly Below Fair Value

  • Analyst Forecast

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 1696?

Other financial metrics that can be useful for relative valuation.

1696 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue2x
Enterprise Value/EBITDA11.2x
PEG Ratio1x

Price to Earnings Ratio vs Peers

How does 1696's PE Ratio compare to its peers?

1696 PE Ratio vs Peers
The above table shows the PE ratio for 1696 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyPEEstimated GrowthMarket Cap
Peer Average31.1x
1858 Beijing Chunlizhengda Medical Instruments
12.8xn/aHK$8.0b
1789 AK Medical Holdings
71.8x38.8%HK$7.7b
1302 LifeTech Scientific
33.4xn/aHK$11.3b
3600 Modern Dental Group
6.2x20.4%HK$2.2b
1696 Sisram Medical
22.1x22.3%HK$5.4b

Price-To-Earnings vs Peers: 1696 is good value based on its Price-To-Earnings Ratio (22.1x) compared to the peer average (31.1x).


Price to Earnings Ratio vs Industry

How does 1696's PE Ratio compare vs other companies in the Asian Medical Equipment Industry?

Price-To-Earnings vs Industry: 1696 is expensive based on its Price-To-Earnings Ratio (22.1x) compared to the Hong Kong Medical Equipment industry average (16.3x)


Price to Earnings Ratio vs Fair Ratio

What is 1696's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

1696 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio22.1x
Fair PE Ratio20.8x

Price-To-Earnings vs Fair Ratio: 1696 is expensive based on its Price-To-Earnings Ratio (22.1x) compared to the estimated Fair Price-To-Earnings Ratio (20.8x).


Share Price vs Fair Value

What is the Fair Price of 1696 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 1696 (HK$11.62) is trading below our estimate of fair value (HK$11.83)

Significantly Below Fair Value: 1696 is trading below fair value, but not by a significant amount.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.


Discover undervalued companies

Future Growth

How is Sisram Medical forecast to perform in the next 1 to 3 years based on estimates from 2 analysts?

Future Growth Score

4/6

Future Growth Score 4/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


22.3%

Forecasted annual earnings growth

Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: 1696's forecast earnings growth (22.3% per year) is above the savings rate (1.6%).

Earnings vs Market: 1696's earnings (22.3% per year) are forecast to grow faster than the Hong Kong market (16.8% per year).

High Growth Earnings: 1696's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: 1696's revenue (17.8% per year) is forecast to grow faster than the Hong Kong market (10% per year).

High Growth Revenue: 1696's revenue (17.8% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: 1696's Return on Equity is forecast to be low in 3 years time (12%).


Discover growth companies

Past Performance

How has Sisram Medical performed over the past 5 years?

Past Performance Score

5/6

Past Performance Score 5/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


16.8%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: 1696 has high quality earnings.

Growing Profit Margin: 1696's current net profit margins (10.6%) are higher than last year (8.2%).


Past Earnings Growth Analysis

Earnings Trend: 1696's earnings have grown by 16.8% per year over the past 5 years.

Accelerating Growth: 1696's earnings growth over the past year (134.2%) exceeds its 5-year average (16.8% per year).

Earnings vs Industry: 1696 earnings growth over the past year (134.2%) exceeded the Medical Equipment industry 35.4%.


Return on Equity

High ROE: 1696's Return on Equity (8.1%) is considered low.


Discover strong past performing companies

Financial Health

How is Sisram Medical's financial position?

Financial Health Score

6/6

Financial Health Score 6/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Debt Coverage

  • Interest Coverage

Financial Position Analysis

Short Term Liabilities: 1696's short term assets ($297.6M) exceed its short term liabilities ($83.6M).

Long Term Liabilities: 1696's short term assets ($297.6M) exceed its long term liabilities ($43.0M).


Debt to Equity History and Analysis

Debt Level: 1696 has more cash than its total debt.

Reducing Debt: 1696's debt to equity ratio has reduced from 492.5% to 1.8% over the past 5 years.

Debt Coverage: 1696's debt is well covered by operating cash flow (443.9%).

Interest Coverage: 1696's interest payments on its debt are well covered by EBIT (29.2x coverage).


Balance Sheet


Discover healthy companies

Dividend

What is Sisram Medical current dividend yield, its reliability and sustainability?

Dividend Score

0/6

Dividend Score 0/6

  • Notable Dividend

  • High Dividend

  • Stable Dividend

  • Growing Dividend

  • Earnings Coverage

  • Cash Flow Coverage


1.35%

Current Dividend Yield

Upcoming Dividend Payment

TodayAug 16 2022Ex Dividend DateAug 19 2022Dividend Pay DateSep 02 202214 days from Ex DividendBuy in the next 2 days to receive the upcoming dividend

Dividend Yield vs Market

Notable Dividend: 1696's dividend (1.35%) isn’t notable compared to the bottom 25% of dividend payers in the Hong Kong market (2.87%).

High Dividend: 1696's dividend (1.35%) is low compared to the top 25% of dividend payers in the Hong Kong market (8.31%).


Stability and Growth of Payments

Stable Dividend: 1696 is not paying a notable dividend for the Hong Kong market, therefore no need to check if payments are stable.

Growing Dividend: 1696 is not paying a notable dividend for the Hong Kong market, therefore no need to check if payments are increasing.


Earnings Payout to Shareholders

Earnings Coverage: 1696 is not paying a notable dividend for the Hong Kong market.


Cash Payout to Shareholders

Cash Flow Coverage: 1696 is not paying a notable dividend for the Hong Kong market.


Discover strong dividend paying companies

Management

How experienced are the management team and are they aligned to shareholders interests?

4.0yrs

Average management tenure


CEO

Lior Dayan (52 yo)

5.17yrs

Tenure

US$1,592,000

Compensation

Mr. Lior Moshe Dayan has been Chief Executive Officer and Executive Director at Sisram Medical Ltd since June 6, 2017 and is responsible for its overall and day-to-day management and development. Mr. Dayan...


CEO Compensation Analysis

Compensation vs Market: Lior's total compensation ($USD1.59M) is above average for companies of similar size in the Hong Kong market ($USD548.44K).

Compensation vs Earnings: Lior's compensation has increased by more than 20% in the past year.


Leadership Team

Experienced Management: 1696's management team is considered experienced (4 years average tenure).


Board Members

Experienced Board: 1696's board of directors are considered experienced (5 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Sisram Medical Ltd's employee growth, exchange listings and data sources


Key Information

  • Name: Sisram Medical Ltd
  • Ticker: 1696
  • Exchange: SEHK
  • Founded: 2013
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Implied Market Cap: HK$5.417b
  • Shares outstanding: 466.16m
  • Website: https://www.sisram-medical.com

Number of Employees


Location

  • Sisram Medical Ltd
  • Ofek Building 15
  • HaHarash Street 18
  • Caesarea
  • 3079895
  • Israel

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/08/16 00:00
End of Day Share Price2022/08/16 00:00
Earnings2021/12/31
Annual Earnings2021/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.